Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus

Gastroenterology. 2013 Dec;145(6):1237-44.e1-5. doi: 10.1053/j.gastro.2013.08.052. Epub 2013 Aug 30.

Abstract

Background & aims: Insulin and leptin have proliferative and anti-apoptotic effects. Ghrelin promotes gastric emptying and secretion of growth hormone and inhibits inflammation. We assessed whether diabetes mellitus and serum levels of insulin, leptin, and ghrelin are associated with gastroesophageal reflux disease (GERD) and Barrett's esophagus.

Methods: We conducted a case-control study in 822 men undergoing colorectal cancer screening who were recruited to also undergo upper endoscopy. We identified 70 with Barrett's esophagus; 80 additional men with Barrett's esophagus were recruited shortly after their clinical diagnoses. Serum levels of insulin, leptin, and ghrelin were assayed in all 104 fasting men with Barrett's esophagus without diabetes and 271 without diabetes or Barrett's esophagus. Logistic regression was used to estimate the effects of diabetes and levels of insulin, leptin, and ghrelin on GERD and Barrett's esophagus.

Results: Among men with GERD, diabetes was inversely associated with Barrett's esophagus (adjusted odds ratio [OR] = 0.383; 95% confidence interval [CI]: 0.179-0.821). Among nondiabetics, hyperinsulinemia was positively associated with Barrett's esophagus, but the association was attenuated by adjustment for leptin and ghrelin. Leptin was positively associated with Barrett's esophagus, adjusting for obesity, GERD, and levels of insulin and ghrelin (OR for 3(rd) vs 1(st) tertile = 3.25; 95% CI: 1.29-8.17); this association was stronger in men with GERD (P = .01 for OR heterogeneity). Ghrelin was positively associated with Barrett's esophagus (OR for an increment of 400 pg/mL = 1.39; 95% CI: 1.09-1.76), but inversely associated with GERD (OR for 3(rd) vs 1(st) tertile = 0.364; 95% CI: 0.195-0.680).

Conclusions: Based on a case-control study, leptin was associated with Barrett's esophagus, particularly in men with GERD. Serum insulin level was associated with Barrett's esophagus, but might be mediated by leptin. Serum ghrelin was inversely associated with GERD, as hypothesized, but positively associated with Barrett's esophagus, contrary to our hypothesis. Additional studies are needed in men and women to replicate these findings.

Keywords: BE; Barrett's esophagus; CI; CRC; GERD; Gastroesophageal Reflux; Ghrelin; Insulin; LA; Leptin; Los Angeles; OR; PPI; colorectal cancer; confidence interval; gastroesophageal reflux disease; odds ratio; proton pump inhibitor.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Barrett Esophagus / blood
  • Barrett Esophagus / diagnosis
  • Barrett Esophagus / epidemiology*
  • Case-Control Studies
  • Diabetes Complications / blood
  • Diabetes Complications / complications*
  • Endoscopy, Gastrointestinal
  • Gastroesophageal Reflux / blood
  • Gastroesophageal Reflux / diagnosis
  • Gastroesophageal Reflux / epidemiology*
  • Ghrelin / blood*
  • Humans
  • Incidence
  • Insulin / blood*
  • Leptin / blood*
  • Logistic Models
  • Male
  • Middle Aged
  • Risk Factors

Substances

  • Ghrelin
  • Insulin
  • Leptin